Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI

JAMA - Journal of the American Medical Association - Tập 304 Số 16 - Trang 1821 - 2010
Jessica L. Mega1, Tabassome Simon2, Jean‐Philippe Collet3, Jeffrey L. Anderson4, Elliott M. Antman5, Kevin P. Bliden6, Christopher P. Cannon5, Nicolas Danchin7, Betti Giusti8, Helen Parise, Benjamin D. Horne4, Jean‐Sébastien Hulot9, Adnan Kastrati10, Gilles Montalescot9, Franz‐Josef Neumann11, Lei Shen12, Dirk Sibbing10, Philippe Gabríel Steg3, Dietmar Trenk11, Stephen D. Wiviott5, Marc S. Sabatine5
1TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA. [email protected]
2Assistance Publique – Hôpitaux de Paris
3Institut National de la Santé et de la Recherche Médicale
4Primary Children's Medical Center
5Harvard University
6Sinai Hospital of Baltimore
7Hôpital Européen Georges Pompidou
8University of Florence
9Sorbonne Université
10Deutsches Herzzentrum Munchen
11Univ. of Freiburg
12Eli-Lilly.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Thông tin
Thông tin xuất bản

JAMA - Journal of the American Medical Association

Tập 304 Số 16

1821

Thông tin tác giả